Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors

Lorenzo Galluzzi; Juliette Humeau; Aitziber Buqué; Laurence Zitvogel; Guido Guido Kroemer

doi:10.1038/s41571-020-0413-z

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2021

Immune checkpoint inhibitors

Guido Guido Kroemer, Laurence Zitvogel

Editorial Material2023

Immunogenic chemotherapy sensitizes RAS-mutated colorectal cancers to immune checkpoint inhibitors

Lucillia Bezu, Oliver Kepp, Guido Guido Kroemer

Article2021

Nephrotoxicity in patients with cancer treated with immune checkpoint inhibitors.

Evangelos Eleutherakis Papaiakovou, Efstathios Kastritis, Flora Zagouri, Dimitra Grapsa, Ioannis Ntanassis-Stathopoulos, Dimitra Stefanou, George Evangelou, Ilias Kotteas, Meletios A Dimopoulos, Konstantinos Syrigos

Article2019

A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in mice

Sarah Lévesque, Julie Le Naour, Federico Pietrocola, Juliette Paillet, Margerie Kremer, Francesca Castoldi, Elisa Elena Baracco, Yan Wang, Erika Vacchelli, Gautier Stoll, Ariane Jolly, Pierre de la Grange, Laurence Zitvogel, Guido Guido Kroemer, Jonathan Pol

Letter2017

Immune checkpoint inhibitors in malignant pleural mesothelioma

Giovanni Luca Ceresoli, Alberto Mantovani